CNX Therapeutics acquires Sativex from Jazz Pharmaceuticals - PharmaTimes Deal strengthens CNS portfolio and ensures continuity of access for MS patients

#CNXTherapeutics #Sativex #nabiximols #JazzPharmaceuticals #plantderivedcannabinoidmedicine #cannabinoidmedicine #CNS #CNSportfolio #patientaccess #multiplesclerosis #MS #MSpatients #marketingauthorisations #commercialpartnerships #manufacturingarrangements #CNSmedicines
zurl.co/X5Tvc

Jazz gets FDA okay for Chimerix brain cancer drug Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 K27M mutations.

#JazzPharmaceuticals has become the first drugmaker to get #FDA approval for a treatment for diffuse midline #glioma with H3 K27M mutations, a rare #braincancer mainly affecting #youngpeople.

pharmaphorum.com/news/jazz-ge...

EC approves Jazz Pharmaceuticals’ Ziihera for advanced biliary tract cancer - PMLiVE Approximately 26% of biliary tract cancer patients globally have HER2-positive disease

#gastrointestinalcancers #EC #JazzPharmaceuticals #Ziihera #zanidatamab #advancedbiliarytractcancer #biliarytractcancer #BTCpatients #HER2targetedbispecificantibody #HERIZONBTC01trial #gallbladdercancer #cholangiocarcinoma #advancedHER2positiveBTC #HER2targetedtherapy
pmlive.com/pharma_news/...

Escuchando al profesor Jaime Espín en la II Jornada de Farmacoeconomía #JazzPharmaceuticals @uji.es

Every single time #jazzpharmaceuticals